Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Opportunistic screening for skin cancer using a mobile unit in Brazil.

Mauad EC, Silva TB, Latorre MR, Vieira RA, Haikel RL Jr, Vazquez VL, Longatto-Filho A.

BMC Dermatol. 2011 Jun 6;11:12. doi: 10.1186/1471-5945-11-12.

2.

Evaluation of the American Academy of Dermatology's National Skin Cancer Early Detection and Screening Program.

Koh HK, Norton LA, Geller AC, Sun T, Rigel DS, Miller DR, Sikes RG, Vigeland K, Bachenberg EU, Menon PA, Billon SF, Goldberg G, Scarborough DA, Ramsdell WM, Muscarella VA, Lew RA.

J Am Acad Dermatol. 1996 Jun;34(6):971-8.

PMID:
8647990
3.

Clinical outcomes from skin screening clinics within a community-based melanoma screening program.

Aitken JF, Janda M, Elwood M, Youl PH, Ring IT, Lowe JB.

J Am Acad Dermatol. 2006 Jan;54(1):105-14.

PMID:
16384764
4.

Total-Body Examination vs Lesion-Directed Skin Cancer Screening.

Hoorens I, Vossaert K, Pil L, Boone B, De Schepper S, Ongenae K, Annemans L, Chevolet I, Brochez L.

JAMA Dermatol. 2016 Jan;152(1):27-34. doi: 10.1001/jamadermatol.2015.2680.

PMID:
26466155
5.

One year experience of a model for melanoma continuous prevention in the city of Jaú (São Paulo), Brazil.

Salvio AG, Assumpção Júnior A, Segalla JG, Panfilo BL, Nicolini HR, Didone R.

An Bras Dermatol. 2011 Jul-Aug;86(4):669-74. English, Portuguese.

6.

Systematic skin cancer screening in Northern Germany.

Breitbart EW, Waldmann A, Nolte S, Capellaro M, Greinert R, Volkmer B, Katalinic A.

J Am Acad Dermatol. 2012 Feb;66(2):201-11. doi: 10.1016/j.jaad.2010.11.016.

PMID:
22074699
8.

Screening for skin cancer.

Helfand M, Mahon SM, Eden KB, Frame PS, Orleans CT.

Am J Prev Med. 2001 Apr;20(3 Suppl):47-58. Review.

PMID:
11306232
9.

Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update.

Ishihara K, Saida T, Otsuka F, Yamazaki N; Prognosis and Statistical Investigation Committee of the Japanese Skin Cancer Society..

Int J Clin Oncol. 2008 Feb;13(1):33-41. doi: 10.1007/s10147-007-0751-1.

PMID:
18307017
10.

[Importance of dermatologic screening within the frame work of a general cancer prevention program].

Lacava V, Salesi N, Ferrone L, Veri A, Lembo R, Masi MC, Rocchi M, Rondinelli R, Parisi E, Grieco T, Balzani A, Clerico R, Innocenzi D, Bottoni U, Calvieri S.

Minerva Med. 2001 Apr;92(2):85-8. Italian.

PMID:
11323570
11.

Digital photography in skin cancer screening by mobile units in remote areas of Brazil.

Silveira CE, Silva TB, Fregnani JH, da Costa Vieira RA, Haikel RL Jr, Syrjänen K, Carvalho AL, Mauad EC.

BMC Dermatol. 2014 Dec 24;14:19. doi: 10.1186/s12895-014-0019-1.

12.

Cutaneous melanoma: a prospective study of 42 cases.

Fernandes NC, Calmon R.

An Bras Dermatol. 2011 Nov-Dec;86(6):1233-5. English, Portuguese.

13.

Diagnosis and management costs of suspicious skin lesions from a population-based melanoma screening programme.

Gordon L, Youl PH, Elwood M, Janda M, Ring IT, Lowe JB, Aitken JF.

J Med Screen. 2007;14(2):98-102.

PMID:
17626710
14.
15.

The first 15 years of the American Academy of Dermatology skin cancer screening programs: 1985-1999.

Geller AC, Zhang Z, Sober AJ, Halpern AC, Weinstock MA, Daniels S, Miller DR, Demierre MF, Brooks DR, Gilchrest BA.

J Am Acad Dermatol. 2003 Jan;48(1):34-41.

PMID:
12522368
16.

Melanoma/skin cancer screening in a Mediterranean country: results of the Euromelanoma Screening Day Campaign in Greece.

Stratigos A, Nikolaou V, Kedicoglou S, Antoniou C, Stefanaki I, Haidemenos G, Katsambas AD.

J Eur Acad Dermatol Venereol. 2007 Jan;21(1):56-62.

PMID:
17207168
17.

Increased melanoma risk in Parkinson disease: a prospective clinicopathological study.

Bertoni JM, Arlette JP, Fernandez HH, Fitzer-Attas C, Frei K, Hassan MN, Isaacson SH, Lew MF, Molho E, Ondo WG, Phillips TJ, Singer C, Sutton JP, Wolf JE Jr; North American Parkinson's and Melanoma Survey Investigators..

Arch Neurol. 2010 Mar;67(3):347-52. doi: 10.1001/archneurol.2010.1.

PMID:
20212233
18.

Evaluation of melanoma/skin cancer screening in Massachusetts. Preliminary results.

Koh HK, Caruso A, Gage I, Geller AC, Prout MN, White H, O'Connor K, Balash EM, Blumental G, Rex IH Jr, et al.

Cancer. 1990 Jan 15;65(2):375-9.

19.

[The 'freckle bus' campaign; an unhealthy phenomenon or a sensible experiment?].

Krol AD, van der Rhee HJ, Dieleman M, Welvaart K.

Ned Tijdschr Geneeskd. 1990 Oct 20;134(42):2047-50. Dutch.

PMID:
2234178
20.

Effectiveness of skin cancer screening for individuals age 14 to 34 years.

Schmitt J, Seidler A, Heinisch G, Sebastian G.

J Dtsch Dermatol Ges. 2011 Aug;9(8):608-16. doi: 10.1111/j.1610-0387.2011.07655.x. English, German.

PMID:
21501381
Items per page

Supplemental Content

Support Center